pharma · Lupus Nephritis · Generalized Myasthenia Gravis · AUPH
Aurinia Pharmaceuticals
Aurora Pharmaceutical is a pharma organization headquartered in northfield, USA. It trades on NYSE under ticker AUPH. Primary therapeutic focus areas include Lupus Nephritis, Generalized Myasthenia Gravis, Dry Eye Syndro
1196 Hwy 3 South, Northfield, MN 55057, US HQ
2007 Founded
81 Employees
Public company Type
AUPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1196 Hwy 3 South, Northfield, MN 55057, US
- Founded
- 2007
- Employees
- 81
- Programs
- 14
- Drugs
- 10
- Patents
- 7
Simvastatin
Phase 1 · small molecule · Drug-drug Interaction
Simvastatin for Drug-drug Interaction is a Phase 1 program (small_molecule) at Aurinia Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code AUR-VCS-2021-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aurinia Pharmaceuticals
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Drug-drug Interaction
- Status
- completed
- Trials
- 1